Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Impact of Phosphate Supplementation on FGF23 Concentrations in Hypophosphatemia
NCT07827989Recruiting
- Sponsor
- Centre Hospitalier Universitaire de Clermont-Ferrand
- Start
- Jun 2026
- Primary completion
- May 2027
- Countries
- 1
01
Overview
Single-arm trial, sponsored by Centre Hospitalier Universitaire de Clermont-Ferrand. Primary endpoint: Plasma FGF23 levels up to 21 days. Started Jun 2026; status: recruiting.
Beyond the preview
Go deeper on NCT07827989.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07827989.